Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Surgery PartnersSGRY -2.61%66 FCF Margin % is -0.53% as of Mar. 2026. GuruFocus rates SGRY with a GF Score™ of 66/100 and a GF Value™ of $26.81 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 667 Healthcare Providers & Services companies, Surgery Partners ranks better than 59.97% on this metric.
The historical data trend for Surgery Partners's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Surgery Partners's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgery Partners FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Surgery Partners's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Surgery Partners's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgery Partners (SGRY) has a FCF Margin % of -0.53% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Surgery Partners and its competitors. Over the past decade, Surgery Partners' FCF Margin % has ranged from 1.33 to 10.97. According to the industry distribution chart, Surgery Partners ranks #267 out of 667 companies in the Healthcare Providers & Services industry, placing it in the top 40%.
Is Surgery Partners' FCF Margin % too high?
Surgery Partners' current FCF Margin % is -0.53%. Over the past 10 years, this metric has ranged from a low of 1.33 to a high of 10.97. Based on the distribution chart, Surgery Partners ranks #267 out of 667 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Surgery Partners has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Surgery Partners' FCF Margin % compare to AVAH and ASTH?
According to the Healthcare Providers & Services industry distribution chart, Surgery Partners ranks #267 out of 667 companies for FCF Margin %. This puts Surgery Partners in the upper half of its industry. The industry median FCF Margin % is 3.15. Historically, Surgery Partners' own FCF Margin % has ranged from 1.33 to 10.97 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.15, based on 667 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Surgery Partners and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgery Partners's current FCF Margin % is -0.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgery Partners stock overvalued right now?
Based on GuruFocus' analysis, Surgery Partners (SGRY) is currently considered Possible Value Trap. The stock's GF Value™ is $26.81, compared to a current price of $14.92 — trading 44.3% below its estimated fair value. The current FCF Margin % is -0.53%. Surgery Partners' overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Surgery Partners (SGRY), the current FCF Margin % is -0.53% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Surgery Partners (SGRY) Overvalued in 2026?
Based on GuruFocus' analysis, Surgery Partners stock appears to be undervalued.
The current stock price of $14.92 is trading 44.3% below its estimated GF Value™ of $26.81.
GuruFocus considers Surgery Partners to be Possible Value Trap.
Key valuation signals for SGRY:
FCF Margin %: -0.53%
GF Value™: $26.81 vs. price of $14.92 (44.3% below fair value)
No single metric tells the full story. See the SGRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
66GF Score
Get the complete analysis for SGRY
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGRY has been successfully added to your 
